Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275691 · ClinicalTrials.gov registry record
Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 867
- Enrollment target
NCT00275691: Completed study, sponsored by Mayo Clinic.
NCT00275691 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 867 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00275691 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 867 participants
- Enrollment target
Study Summary
Community acquired pneumonia(CAP) is a common cause of morbidity and mortality. The diagnosis of CAP from the microbiology perspective has been challenging. Recent reports suggest the utility of real-time PCR for rapid and accurate diagnoses of these pathogens. Real-Time PCR tests, using the LightCycler instrument, will be performed on excess or additional specimens after extraction of nucleic acid.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 867 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-06 |
What the finished NCT00275691 record still lists
NCT00275691 is an observational study that tracks outcomes without assigning an intervention. The registered 867 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00275691 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00275691 about?
NCT00275691 is a clinical study titled "Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR". Community acquired pneumonia(CAP) is a common cause of morbidity and mortality. The diagnosis of CAP from the microbiology perspective has been challenging. Recent reports suggest the utility of real-time PCR for rapid and accurate diagnoses of these pathogens. Real-Time PCR tests, using the LightCy...
What is the current status of trial NCT00275691?
This trial is currently completed. The enrollment target is 867 participants. The study started on 2005-10. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00275691?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04933552 · 867 participants
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT05369052 · 865 participants · Phase 3
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia